Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial

Christoph Kuemmerli, Robert S Fichtinger, Alma Moekotte, Luca A Aldrighetti, Somaiah Aroori, Marc G H Besselink, Mathieu D'Hondt, Rafael Díaz-Nieto, Bjørn Edwin, Mikhail Efanov, Giuseppe M Ettorre, Krishna V Menon, Aali J Sheen, Zahir Soonawalla, Robert Sutcliffe, Roberto I Troisi, Steven A White, Lloyd Brandts, Gerard J P van Breukelen, Jasper Sijberden, Siân A Pugh, Zina Eminton, John N Primrose, Ronald van Dam, Mohammed Abu Hilal, ORANGE trials collaborative, Christoph Kuemmerli, Robert S Fichtinger, Alma Moekotte, Luca A Aldrighetti, Somaiah Aroori, Marc G H Besselink, Mathieu D'Hondt, Rafael Díaz-Nieto, Bjørn Edwin, Mikhail Efanov, Giuseppe M Ettorre, Krishna V Menon, Aali J Sheen, Zahir Soonawalla, Robert Sutcliffe, Roberto I Troisi, Steven A White, Lloyd Brandts, Gerard J P van Breukelen, Jasper Sijberden, Siân A Pugh, Zina Eminton, John N Primrose, Ronald van Dam, Mohammed Abu Hilal, ORANGE trials collaborative

Abstract

Background: A shift towards parenchymal-sparing liver resections in open and laparoscopic surgery emerged in the last few years. Laparoscopic liver resection is technically feasible and safe, and consensus guidelines acknowledge the laparoscopic approach in the posterosuperior segments. Lesions situated in these segments are considered the most challenging for the laparoscopic approach. The aim of this trial is to compare the postoperative time to functional recovery, complications, oncological safety, quality of life, survival and costs after laparoscopic versus open parenchymal-sparing liver resections in the posterosuperior liver segments within an enhanced recovery setting.

Methods: The ORANGE Segments trial is an international multicentre randomised controlled superiority trial conducted in centres experienced in laparoscopic liver resection. Eligible patients for minor resections in the posterosuperior segments will be randomised in a 1:1 ratio to undergo laparoscopic or open resections in an enhanced recovery setting. Patients and ward personnel are blinded to the treatment allocation until postoperative day 4 using a large abdominal dressing. The primary endpoint is time to functional recovery. Secondary endpoints include intraoperative outcomes, length of stay, resection margin, postoperative complications, 90-day mortality, time to adjuvant chemotherapy initiation, quality of life and overall survival. Laparoscopic liver surgery of the posterosuperior segments is hypothesised to reduce time to functional recovery by 2 days in comparison with open surgery. With a power of 80% and alpha of 0.04 to adjust for interim analysis halfway the trial, a total of 250 patients are required to be randomised.

Discussion: The ORANGE Segments trial is the first multicentre international randomised controlled study to compare short- and long-term surgical and oncological outcomes of laparoscopic and open resections in the posterosuperior segments within an enhanced recovery programme.

Trial registration: ClinicalTrials.gov NCT03270917 . Registered on September 1, 2017. Before start of inclusion.

Protocol version: version 12, May 9, 2017.

Keywords: Enhanced recovery; Laparoscopy; Liver surgery; Posterosuperior segments; Randomised controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
ORANGE Segments trial flow diagram
Fig. 2
Fig. 2
Functional recovery criteria

References

    1. D'Angelica M, Kornprat P, Gonen M, DeMatteo RP, Fong Y, Blumgart LH, et al. Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases. Ann Surg Oncol. 2011;18(4):1096–1103. doi: 10.1245/s10434-010-1409-1.
    1. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J, EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421–430. doi: 10.1016/S0168-8278(01)00130-1.
    1. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L, Ferrone CR, Zhu AX, Bauer TW, Walters DM, Gamblin TC, Nguyen KT, Turley R, Popescu I, Hubert C, Meyer S, Schulick RD, Choti MA, Gigot JF, Mentha G, Pawlik TM. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140–3145. doi: 10.1200/JCO.2011.35.6519.
    1. Berardi G, Van Cleven S, Fretland AA, Barkhatov L, Halls M, Cipriani F, et al. Evolution of laparoscopic liver surgery from innovation to implementation to mastery: perioperative and oncologic outcomes of 2,238 patients from 4 European specialized centers. J Am Coll Surg. 2017;225(5):639–649. doi: 10.1016/j.jamcollsurg.2017.08.006.
    1. Martinez-Cecilia D, Cipriani F, Shelat V, Ratti F, Tranchart H, Barkhatov L, et al. Laparoscopic versus open liver resection for colorectal metastases in elderly and octogenarian patients: a multicenter propensity score based analysis of short- and long-term outcomes. Ann Surg. 2017;265(6):1192–1200. doi: 10.1097/SLA.0000000000002147.
    1. Coles SR, Besselink MG, Serin KR, Alsaati H, Di Gioia P, Samim M, et al. Total laparoscopic management of lesions involving liver segment 7. Surg Endosc. 2015;29(11):3190–3195. doi: 10.1007/s00464-014-4052-2.
    1. Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, Pawlik TM. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review. J Gastrointest Surgery. 2017;21(6):1076–1085. doi: 10.1007/s11605-017-3397-y.
    1. Okumura S, Tabchouri N, Leung U, Tinguely P, Louvet C, Beaussier M, Gayet B, Fuks D. Laparoscopic parenchymal-sparing hepatectomy for multiple colorectal liver metastases improves outcomes and salvageability: a propensity score-matched analysis. Ann Surg Oncol. 2019;26(13):4576–4586. doi: 10.1245/s10434-019-07902-x.
    1. D'Hondt M, Ververken F, Nuytens F. Laparoscopic parenchymal preserving liver resections for colorectal liver metastases in the era of highly effective systemic therapy and selective internal radiation therapy can often prevent a hemihepatectomy. (With video) Surg Oncol. 2017;26(4):345–346. doi: 10.1016/j.suronc.2017.07.009.
    1. Martinez-Cecilia D, Fontana M, Siddiqi NN, Halls M, Barbaro S, Abu-Hilal M. Laparoscopic parenchymal sparing resections in segment 8: techniques for a demanding and infrequent procedure. Surg Endosc. 2018;32(4):2012–2019. doi: 10.1007/s00464-017-5897-y.
    1. Berardi G, Igarashi K, Li CJ, Ozaki T, Mishima K, Nakajima K, Honda M, Wakabayashi G. Parenchymal sparing anatomical liver resections with full laparoscopic approach: description of technique and short-term results. Ann Surg. 2019;273(4):785–791. doi: 10.1097/SLA.0000000000003575.
    1. Ban D, Tanabe M, Ito H, Otsuka Y, Nitta H, Abe Y, Hasegawa Y, Katagiri T, Takagi C, Itano O, Kaneko H, Wakabayashi G. A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci. 2014;21(10):745–753. doi: 10.1002/jhbp.166.
    1. Halls MC, Berardi G, Cipriani F, Barkhatov L, Lainas P, Harris S, D'Hondt M, Rotellar F, Dagher I, Aldrighetti L, Troisi RI, Edwin B, Abu Hilal M. Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection. The British journal of surgery. 2018;105(9):1182–1191. doi: 10.1002/bjs.10821.
    1. Kawaguchi Y, Fuks D, Kokudo N, Gayet B. Difficulty of laparoscopic liver resection: proposal for a new classification. Ann Surg. 2018;267(1):13–17. doi: 10.1097/SLA.0000000000002176.
    1. Shelat VG, Serin K, Samim M, Besselink MG, Al Saati H, Gioia PD, et al. Outcomes of repeat laparoscopic liver resection compared to the primary resection. World J Surgery. 2014;38(12):3175–3180. doi: 10.1007/s00268-014-2728-3.
    1. Shelat VG, Cipriani F, Basseres T, Armstrong TH, Takhar AS, Pearce NW, AbuHilal M. Pure laparoscopic liver resection for large malignant tumors: does size matter? Ann Surg Oncol. 2015;22(4):1288–1293. doi: 10.1245/s10434-014-4107-6.
    1. Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, Asbun H, OʼRourke N, Tanabe M, Koffron AJ, Tsung A, Soubrane O, Machado MA, Gayet B, Troisi RI, Pessaux P, van Dam R, Scatton O, Abu Hilal M, Belli G, Kwon CH, Edwin B, Choi GH, Aldrighetti LA, Cai X, Cleary S, Chen KH, Schön MR, Sugioka A, Tang CN, Herman P, Pekolj J, Chen XP, Dagher I, Jarnagin W, Yamamoto M, Strong R, Jagannath P, Lo CM, Clavien PA, Kokudo N, Barkun J, Strasberg SM. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261(4):619–629. doi: 10.1097/SLA.0000000000001184.
    1. Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, Aroori S, Belli G, Besselink M, Briceno J, Gayet B, D’Hondt M, Lesurtel M, Menon K, Lodge P, Rotellar F, Santoyo J, Scatton O, Soubrane O, Sutcliffe R, van Dam R, White S, Halls MC, Cipriani F, van der Poel M, Ciria R, Barkhatov L, Gomez-Luque Y, Ocana-Garcia S, Cook A, Buell J, Clavien PA, Dervenis C, Fusai G, Geller D, Lang H, Primrose J, Taylor M, van Gulik T, Wakabayashi G, Asbun H, Cherqui D. The Southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation. Ann Surg. 2018;268(1):11–18. doi: 10.1097/SLA.0000000000002524.
    1. Scuderi V, Barkhatov L, Montalti R, Ratti F, Cipriani F, Pardo F, Tranchart H, Dagher I, Rotellar F, Abu Hilal M, Edwin B, Vivarelli M, Aldrighetti L, Troisi RI. Outcome after laparoscopic and open resections of posterosuperior segments of the liver. Br J Surgery. 2017;104(6):751–759. doi: 10.1002/bjs.10489.
    1. Xiao L, Xiang LJ, Li JW, Chen J, Fan YD, Zheng SG. Laparoscopic versus open liver resection for hepatocellular carcinoma in posterosuperior segments. Surg Endosc. 2015;29(10):2994–3001. doi: 10.1007/s00464-015-4214-x.
    1. Cho JY, Han HS, Yoon YS, Choi Y, Lee W. Outcomes of laparoscopic right posterior sectionectomy in patients with hepatocellular carcinoma in the era of laparoscopic surgery. Surgery. 2015;158(1):135–141. doi: 10.1016/j.surg.2015.02.007.
    1. Guro H, Cho JY, Han HS, Yoon YS, Choi Y, Jang JS, Kwon SU, Kim S, Choi JK. Laparoscopic liver resection of hepatocellular carcinoma located in segments 7 or 8. Surg Endosc. 2018;32(2):872–878. doi: 10.1007/s00464-017-5756-x.
    1. D'Hondt M, Tamby E, Boscart I, Turcotte S, Parmentier I, Pottel H, et al. Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments: a case-matched study. Surg Endosc. 2018;32(3):1478–1485. doi: 10.1007/s00464-017-5835-z.
    1. Cipriani F, Shelat VG, Rawashdeh M, Francone E, Aldrighetti L, Takhar A, Armstrong T, Pearce NW, Abu Hilal M. Laparoscopic parenchymal-sparing resections for nonperipheral liver lesions, the diamond technique: technical aspects, clinical outcomes, and oncologic efficiency. J Am Coll Surg. 2015;221(2):265–272. doi: 10.1016/j.jamcollsurg.2015.03.029.
    1. Kazaryan AM, Rosok BI, Marangos IP, Rosseland AR, Edwin B. Comparative evaluation of laparoscopic liver resection for posterosuperior and anterolateral segments. Surg Endosc. 2011;25(12):3881–3889. doi: 10.1007/s00464-011-1815-x.
    1. Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters K, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS, World Consensus Conference on Laparoscopic Surgery The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009;250(3):825–830. doi: 10.1097/SLA.0b013e3181b3b2d8.
    1. Syn NL, Kabir T, Koh YX, Tan HL, Wang LZ, Chin BZ, Wee I, Teo JY, Tai BC, Goh BKP. Survival advantage of laparoscopic versus open resection for colorectal liver metastases: a meta-analysis of individual patient data from randomized trials and propensity-score matched studies. Ann Surg. 2019;272(2):253–265. doi: 10.1097/SLA.0000000000003672.
    1. Di Fabio F, Samim M, Di Gioia P, Godeseth R, Pearce NW, Abu HM. Laparoscopic major hepatectomies: clinical outcomes and classification. World J Surg. 2014;38(12):3169–3174. doi: 10.1007/s00268-014-2724-7.
    1. Lim C, Ishizawa T, Miyata A, Mise Y, Sakamoto Y, Hasegawa K, Sugawara Y, Kokudo N. Surgical indications and procedures for resection of hepatic malignancies confined to segment VII. Ann Surg. 2016;263(3):529–537. doi: 10.1097/SLA.0000000000001118.
    1. Melloul E, Hubner M, Scott M, Snowden C, Prentis J, Dejong CH, et al. Guidelines for perioperative care for liver surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg. 2016;40(10):2425–2440. doi: 10.1007/s00268-016-3700-1.
    1. Ni CY, Yang Y, Chang YQ, Cai H, Xu B, Yang F, Lau WY, Wang ZH, Zhou WP. Fast-track surgery improves postoperative recovery in patients undergoing partial hepatectomy for primary liver cancer: a prospective randomized controlled trial. Eur J Surg Oncol. 2013;39(6):542–547. doi: 10.1016/j.ejso.2013.03.013.
    1. Lu H, Fan Y, Zhang F, Li G, Zhang C, Lu L. Fast-track surgery improves postoperative outcomes after hepatectomy. Hepatogastroenterology. 2014;61(129):168–172.
    1. He F, Lin X, Xie F, Huang Y, Yuan R. The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer. Clin Transl Oncol. 2015;17(9):694–701. doi: 10.1007/s12094-015-1296-9.
    1. Jones C, Kelliher L, Dickinson M, Riga A, Worthington T, Scott MJ, Vandrevala T, Fry CH, Karanjia N, Quiney N. Randomized clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surgery. 2013;100(8):1015–1024. doi: 10.1002/bjs.9165.
    1. Hughes MJ, McNally S, Wigmore SJ. Enhanced recovery following liver surgery: a systematic review and meta-analysis. HPB. 2014;16(8):699–706. doi: 10.1111/hpb.12245.
    1. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346(jan08 15):e7586. doi: 10.1136/bmj.e7586.
    1. van Dam RM, Hendry PO, Coolsen MM, Bemelmans MH, Lassen K, Revhaug A, Fearon KC, Garden OJ, Dejong CH, Enhanced Recovery After Surgery (ERAS) Group Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br J Surg. 2008;95(8):969–975. doi: 10.1002/bjs.6227.
    1. van Dam RM, Wong-Lun-Hing EM, van Breukelen GJ, Stoot JH, van der Vorst JR, Bemelmans MH, et al. Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS(R) programme (ORANGE II-trial): study protocol for a randomised controlled trial. Trials. 2012;13(1):54. doi: 10.1186/1745-6215-13-54.
    1. Suurmeijer TP, Doeglas DM, Moum T, Briançon S, Krol B, Sanderman R, Guillemin F, Bjelle A, van den Heuvel WJ. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health. 1994;84(8):1270–1273. doi: 10.2105/AJPH.84.8.1270.
    1. Slankamenac K, Nederlof N, Pessaux P, de Jonge J, Wijnhoven BP, Breitenstein S, et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014;260(5):757–762. doi: 10.1097/SLA.0000000000000948.
    1. van den Broek MA, van Dam RM, Malago M, Dejong CH, van Breukelen GJ, Olde Damink SW. Feasibility of randomized controlled trials in liver surgery using surgery-related mortality or morbidity as endpoint. Br J Surg. 2009;96(9):1005–1014. doi: 10.1002/bjs.6663.
    1. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518–526.
    1. DeMets DL, Lan G. The alpha spending function approach to interim data analyses. Cancer Treat Res. 1995;75:1–27. doi: 10.1007/978-1-4615-2009-2_1.
    1. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103–115. doi: 10.2307/2529712.
    1. Scott NW, McPherson GC, Ramsay CR, Campbell MK. The method of minimization for allocation to clinical trials. a review. Control Clin Trials. 2002;23(6):662–674. doi: 10.1016/S0197-2456(02)00242-8.
    1. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009;250(2):177–186. doi: 10.1097/SLA.0b013e3181afde41.
    1. Porembka MR, Hall BL, Hirbe M, Strasberg SM. Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the American College of Surgeons national surgical quality improvement program. J Am Coll Surg. 2010;210(3):286–298. doi: 10.1016/j.jamcollsurg.2009.12.004.
    1. Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–1132. doi: 10.1002/hec.1124.
    1. Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ. Quality of life after surgical treatment of colorectal liver metastases. Br J Surg. 2006;93(8):1007–1014. doi: 10.1002/bjs.5387.
    1. Blazeby JM, Fayers P, Conroy T, Sezer O, Ramage J, Rees M, European Organization for Research Treatment of Cancer (EORTC) Quality of Life Group Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg. 2009;96(3):291–298. doi: 10.1002/bjs.6471.
    1. Dunker MS, Stiggelbout AM, van Hogezand RA, Ringers J, Griffioen G, Bemelman WA. Cosmesis and body image after laparoscopic-assisted and open ileocolic resection for Crohn's disease. Surg Endosc. 1998;12(11):1334–1340. doi: 10.1007/s004649900851.
    1. Polle SW, Dunker MS, Slors JF, Sprangers MA, Cuesta MA, Gouma DJ, et al. Body image, cosmesis, quality of life, and functional outcome of hand-assisted laparoscopic versus open restorative proctocolectomy: long-term results of a randomized trial. Surg Endosc. 2007;21(8):1301–1307. doi: 10.1007/s00464-007-9294-9.
    1. Schulz KF, Altman DG, Moher D, Group C CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c332. doi: 10.1136/bmj.c332.
    1. Wong-Lun-Hing EM, van Dam RM, van Breukelen GJ, Tanis PJ, Ratti F, van Hillegersberg R, et al. Randomized clinical trial of open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery after surgery programme (ORANGE II study) Br J Surgery. 2017;104(5):525–535. doi: 10.1002/bjs.10438.
    1. Halls MC, Cherqui D, Taylor MA, Primrose JN, Abu HM. Are the current difficulty scores for laparoscopic liver surgery telling the whole story? An international survey and recommendations for the future. HPB. 2018;20(3):231–236. doi: 10.1016/j.hpb.2017.08.028.
    1. Lee W, Woo JW, Lee JK, Park JH, Kim JY, Kwag SJ, Park T, Jeong SH, Ju YT, Jeong EJ, Lee YJ, Choi SK, Hong SC, Jeong CY. Comparison of learning curves for major and minor laparoscopic liver resection. J Laparoendosc Adv Surg Tech A. 2016;26(6):457–464. doi: 10.1089/lap.2016.0063.
    1. Tomassini F, Scuderi V, Colman R, Vivarelli M, Montalti R, Troisi RI. The single surgeon learning curve of laparoscopic liver resection: a continuous evolving process through stepwise difficulties. Medicine (Baltimore) 2016;95:e5138. doi: 10.1097/MD.0000000000005138.
    1. Vigano L, Laurent A, Tayar C, Tomatis M, Ponti A, Cherqui D. The learning curve in laparoscopic liver resection: improved feasibility and reproducibility. Ann Surg. 2009;250(5):772–782. doi: 10.1097/SLA.0b013e3181bd93b2.
    1. Halls MC, Alseidi A, Berardi G, Cipriani F, Van der Poel M, Davila D, et al. A comparison of the learning curves of laparoscopic liver surgeons in differing stages of the IDEAL paradigm of surgical innovation: standing on the shoulders of pioneers. Ann Surg. 2019;269(2):221–228. doi: 10.1097/SLA.0000000000002996.
    1. Oberkofler CE, Hamming JF, Staiger RD, Brosi P, Biondo S, Farges O, Legemate DA, Morino M, Pinna AD, Pinto-Marques H, Reynolds JV, Campos RR, Rogiers X, Soreide K, Puhan MA, Clavien PA, Rinkes IB. Procedural surgical RCTs in daily practice: do surgeons adopt or is it just a waste of time? Ann Surg. 2019;270(5):727–734. doi: 10.1097/SLA.0000000000003546.
    1. Chapman SJ, Shelton B, Mahmood H, Fitzgerald JE, Harrison EM, Bhangu A. Discontinuation and non-publication of surgical randomised controlled trials: observational study. BMJ (Clinical research ed) 2014;349:g6870.
    1. Giovinazzo F, Kuemmerli C, Moekotte A, Rawashdeh A, Suhool A, Armstrong T, Primrose J, Abu Hilal M. The impact of enhanced recovery on open and laparoscopic liver resections. Updates in surgery. 2020;72(3):649–657. doi: 10.1007/s13304-020-00786-7.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever